Fangda, Davis Polk and Conyers advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed a successful listing on the Shanghai Stock Exchange’s STAR Market. InnoCare...
InnoCare Pharma Limited’s Listing on Shanghai Stock Exchange
BeiGene’s $3.5 Billion Listing in Shanghai
Fangda Partners advised BeiGene, while Davis Polk advised the representatives of the several underwriters on the deal. BeiGene executed a US$3.5 billion initial public offering and listing...